Lexicon Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that complet…

Biotechnology
US, The Woodlands [HQ]

Lobbying Analysis

Lexicon Pharmaceuticals, Inc. has no lobbying expenses in our database.

History

Download
FY Quarter Expense For Lobby Disclosure LDA Reference
No data
End of LXRX's Analysis
CIK: 1062822 CUSIP: 528872302 ISIN: US5288723027 LEI: - UEI: -
Secondary Listings
LXRX has no secondary listings inside our databases.